Fig. 1: Overall survival of patients after COVID-19 diagnosis. | Leukemia

Fig. 1: Overall survival of patients after COVID-19 diagnosis.

From: Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Fig. 1

Overall survival was estimated using the Kaplan–Meier method, considering death due to any cause as an event and time from COVID-19 infection to the last date of follow-up as survival time.

Back to article page